Liraglutide, marketed under names like Victoza and Saxenda, typically requires daily injections and is approved at different dosages for diabetes and weight management
When it comes to selecting the right choice, a one-size-fits-all approach doesnt always work
The anticipatory anxiety that characterized early injections fades substantially
Walter, G
doi: 10.3389/fphar.2025.1562896 Received 23 January 2025 Accepted 05 May 2025 Published 02 June 2025 Corrected 09 June 2025 Volume 16 - 2025 Edited by Ahmed Ghallab, Leibniz Research Centre for Working Environment and Human Factors (IfADo), Germany Reviewed by Madlen Matz-Soja, Leipzig University, Germany Mohamed Albadry, University Hospital Jena, Germany Updates Copyright 2025 Sun, Shang, Lv, Liu, Wu and Geng
Standard oral formulations achieve only 0.7% bioavailability, limiting blood level increases compared to IV delivery